Saturday 17 October 2026
Export MRKR’s income statement to Excel — free account
MARKER THERAPEUTICS, INC.
MRKR Healthcare Biotechnology
In the quarter to June 2026, revenue grew 2.75%, EPS grew 69.0% and free cash flow fell 97.8%, each against the same quarter a year earlier.
1.04
0.12
+13.04%
Follow MRKR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Piotroski F-Score |
3 | 3 | 4 | 4 | 3 | 3 | 4 | — | — | — |
P/S ratio |
4.80 | 4.24 | 14.53 | 6.66 | 34.16 | 63.80 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(28.68) | (23.94) | (27.84) | (17.98) | (7.69) | (10.30) | 24.29 | 9.06 | (34.37) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(69.50) | (58.41) | (78.58) | (41.33) | (17.84) | (25.55) | 0.22 | (3.61) | (106.80) | — |
Beneish M-Score |
(2.92) | (1.26) | (2.26) | 3,904.14 | (3.17) | 19.19 | (3.10) | — | — | — |
P/Operating CF |
(12.01) | (5.94) | (20.32) | (3.71) | (14.96) | (12.39) | (28.79) | (17.19) | (15.52) | — |
P/B ratio |
1.36 | 1.50 | 3.42 | 1.19 | 1.65 | 2.49 | 2.98 | 1.79 | 10.52 | — |
Price to Tangible BV |
1.36 | 1.50 | 3.42 | 1.19 | 1.65 | 2.49 | 2.98 | 1.79 | 10.52 | — |
EV/Sales |
1.57 | 1.58 | 10.16 | 3.47 | 14.01 | 44.19 | 0.00 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.62) | (0.96) | (2.05) | (0.45) | (1.09) | (2.36) | (4.79) | (3.05) | (3.95) | — |
EV/FCF |
(0.31) | (0.45) | (1.18) | (0.29) | (0.98) | (1.61) | (4.69) | (3.05) | (3.95) | — |
Quick Ratio |
8.10 | 6.22 | 5.25 | 1.82 | 3.37 | 3.49 | 22.06 | 22.06 | 3.37 | 4.52 |
Current Ratio |
8.39 | 6.36 | 5.57 | 2.14 | 3.56 | 3.81 | 22.83 | 22.11 | 3.40 | 4.56 |
Net Debt/EBITDA |
1.32 | 1.57 | 1.04 | 0.57 | 1.18 | 0.75 | 1.96 | 0.42 | 0.45 | 0.92 |
Debt/Assets |
0.00% | 7.77% | 0.00% | 1.68% | 0.91% | 0.85% | 0.44% | 0.00% | 0.00% | 0.06% |
Debt/Equity |
0.00 | 0.09 | 0.00 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.17 | 0.34 | 0.13 | 0.07 | 0.02 | 0.01 | 0.00 | 0.01 | 0.03 | 0.00 |
Operating CF/Net income |
0.99 | 1.02 | 2.00 | 0.90 | 0.65 | 0.70 | 0.85 | 0.10 | 0.77 | 2.65 |
Capex/Depreciation |
— | — | — | 0.00 | (0.99) | (8.60) | (1.31) | 0.00 | — | — |
Interest Coverage |
— | — | — | (79.77) | (6,925.96) | (194.26) | (20.81) | (584.04) | — | — |
| (68.81%) | (65.81%) | (48.95%) | (94.14%) | (117.42%) | (80.37%) | (41.44%) | (469.72%) | (223.15%) | 32.36% | |
| (59.20%) | (54.82%) | (31.96%) | (58.37%) | (73.63%) | (62.42%) | (39.50%) | (439.54%) | (167.64%) | (33.71%) | |
ROIC |
0.00% | (645.52%) | 0.00% | (147.32%) | (2,225.27%) | (282.93%) | (3,644.97%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(72.42%) | (57.82%) | (58.61%) | (338.68%) | (96.99%) | (133.02%) | (48.80%) | (249.34%) | (300.22%) | (39.70%) |
Average Days of Receivables |
140.93 | 129.95 | 113.30 | 249.53 | 0.06 | 782.39 | 96.21 | 191.71 | 0.00 | — |
Research and Development Expense of Revenue |
332.68% | 204.33% | 314.60% | 340.64% | 2,238.46% | 4,044.73% | 5,987.24% | 60,193.11% | 2,867.83% | 0.00% |
Selling, General and Administrative Expense of Revenue |
117.99% | 64.35% | 225.78% | 322.64% | 1,040.90% | 2,243.34% | 4,679.74% | 11,834.90% | 3,501.97% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
15.15% | 3.73% | 25.92% | 94.05% | 480.31% | 1,120.05% | 2,512.66% | 7,937.18% | 1,495.47% | 0.00% |
Graham Net Nets |
0.74 | 0.66 | 0.29 | 0.08 | 0.30 | 0.09 | 0.33 | 0.56 | 0.10 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(57.05%) | (38.59%) | (17.10%) | (127.07%) | (58.95%) | (42.76%) | (16.32%) | (139.64%) | (28.26%) | — |
Free Cash Flow Yield |
(105.89%) | (82.54%) | (59.42%) | (177.28%) | (41.84%) | (42.94%) | (14.21%) | (13.67%) | (21.94%) | — |
Revenue per Share |
0.23 | 0.73 | 0.38 | 0.42 | 0.16 | 0.10 | 0.05 | 0.11 | 0.19 | 0.00 |
Operating CF per Share |
(0.78) | (1.21) | (1.87) | (3.23) | (3.57) | (4.26) | (4.01) | (7.58) | (8.93) | (9.45) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.59) | (0.41) | (1.97) | (0.08) | (0.08) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.78) | (1.21) | (1.87) | (3.82) | (3.97) | (6.23) | (4.09) | (7.66) | (8.93) | (9.45) |
Cash per Share |
1.11 | 2.14 | 1.72 | 1.41 | 5.69 | 4.54 | 9.63 | 32.34 | 5.43 | 11.40 |
Shareholders Equity per Share |
1.10 | 2.07 | 1.60 | 2.35 | 5.75 | 5.81 | 9.67 | 31.08 | 3.87 | 8.98 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.10 | 2.07 | 1.60 | 2.35 | 5.75 | 5.81 | 9.67 | 31.08 | 3.87 | 8.98 |
Free Cash Flow |
(12.01) | (10.91) | (16.44) | (31.92) | (30.41) | (29.29) | (18.66) | (14.63) | (8.44) | (6.51) |
Working Capital |
16.80 | 18.56 | 14.05 | 8.84 | 33.08 | 18.01 | 43.49 | 59.19 | 3.66 | 6.18 |
Capital Expenditures |
— | — | — | (4.95) | (3.13) | (9.25) | (0.37) | (0.15) | — | — |
Net Current Asset Value |
16.80 | 18.56 | 14.05 | 1.80 | 21.83 | 6.14 | 43.21 | 59.19 | 3.66 | 6.18 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 1.41 | 2.52 | 19.82 | 1.76 | 0.72 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | — | — | 0.30 | 0.31 | 0.30 | 0.69 | 0.00 | — | — |
Cash ROIC |
(35.50%) | (27.65%) | (56.37%) | (99.87%) | (34.52%) | (59.67%) | (21.16%) | (12.08%) | (96.04%) | (46.36%) |
Accounts Receivable Turnover |
1.91 | 3.91 | 1.93 | 2.93 | 2.48 | 0.88 | 2.59 | 3.77 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
1.86 | 1.69 | 1.71 | 1.20 | 0.50 | 0.53 | 0.08 | 0.05 | — | — |
Average Payables |
1.53 | 1.75 | 2.13 | 6.83 | 8.57 | 3.89 | 2.26 | 2.13 | 1.37 | 1.10 |
Average Assets |
20.55 | 19.58 | 25.77 | 51.28 | 56.87 | 45.99 | 54.25 | 33.66 | 6.55 | 7.28 |
Average Common Equity |
17.68 | 16.31 | 16.83 | 31.79 | 35.67 | 35.72 | 51.71 | 31.50 | 4.92 | (7.59) |
Columns are period end dates